Atherosclerosis: Cell biology and lipoproteins-New mechanistic links in atherosclerosis: Chemokines mediating the effects of lipids, platelets and dendritic cells

Current Opinion in Lipidology

Volumn 23, Issue 4, 2012, Pages 400-401

  Karshovska, Ela ^a   Weber, Christian ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; LIPID; LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ATHEROSCLEROSIS; CYTOLOGY; DENDRITIC CELL; HUMAN; NONHUMAN; NOTE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; THROMBOCYTE;

ANIMALS; ATHEROSCLEROSIS; BLOOD PLATELETS; CHEMOKINES; DENDRITIC CELLS; HUMANS; LIPOPROTEINS;

EID: 84863938239     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283555a9c     Document Type: Note

References (14)

1. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17:1410-1422.
2. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008; 8:802-815.
3. Zhou Z, Subramanian P, Sevilmis G, et al. Lipoprotein-derived lysophosphatidic acid enhances atherosclerosis through the release of CXCL1 from endothelium. Cell Metab 2011; 13:592-600.
4. Aoki J, Inoue A, Okudaira S. Two pathways of lysophosphatidic acid production. Biochim Biophys Acta 2008; 1781:513-518.
5. Subramanian P, Karshovska E, Reinhard P, et al. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation. Circ Res 2010; 107:96-105.
6. Koenen RR, Weber C. Platelet-derived chemokines in vascular remodelling and atherosclerosis. Semin Thromb Hemost 2010; 36:163-169.
7. Postea O, Vasina EM, Cauwenberghs S, et al. Role of platelet CX3CR1 in monocyte recruitment to arterial lesions. Arterioscler Thromb Vasc Biol 2012; 32:1186-1193.
8. Zernecke A, Bot I, Djalali-Talab Y, et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008; 102:209-217.
9. Dö ring Y, Manthey H, Drechsler M, et al. Autoantigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 2012; 125:1673-1683.
10. Megens RT, Santosh V, Lievens D, et al. Presence of luminal neutrophil extracellular traps in atherosclerosis. Thromb Haemost 2012; 107:597-598.
11. Drechsler M, Dö ring Y, Megens RT, Soehnlein O. Neutrophilic granulocytes: promiscuous accelerators of atherosclerosis. Thromb Haemost 2011; 106:839-848.
12. Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010; 107:15880-15885.
13. Soehnlein O, Zernecke A, Weber C. Neutrophils launch monocyte extravasation by release of granule proteins. Thromb Haemost 2009; 102:198-205.
14. Weber C, Meiler S, Dö ring Y, et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest 2011; 121:2898-2910.